| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress Disorders, Post-Traumatic | 255 | 2024 | 4575 | 20.030 |
Why?
|
| Fear | 129 | 2024 | 1477 | 18.570 |
Why?
|
| Extinction, Psychological | 55 | 2023 | 371 | 9.360 |
Why?
|
| Amygdala | 76 | 2024 | 1354 | 8.960 |
Why?
|
| Conditioning, Classical | 48 | 2024 | 368 | 7.390 |
Why?
|
| Brain-Derived Neurotrophic Factor | 23 | 2024 | 602 | 4.300 |
Why?
|
| Tacrolimus Binding Proteins | 15 | 2021 | 194 | 3.900 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 14 | 2022 | 52 | 3.790 |
Why?
|
| Memory | 30 | 2024 | 2193 | 3.720 |
Why?
|
| Implosive Therapy | 12 | 2021 | 125 | 3.420 |
Why?
|
| Child Abuse | 36 | 2023 | 1077 | 3.400 |
Why?
|
| Anxiety Disorders | 27 | 2023 | 2720 | 2.960 |
Why?
|
| Learning | 20 | 2023 | 1740 | 2.810 |
Why?
|
| Corticotropin-Releasing Hormone | 19 | 2021 | 361 | 2.650 |
Why?
|
| Cycloserine | 11 | 2019 | 118 | 2.400 |
Why?
|
| Dissociative Disorders | 10 | 2024 | 234 | 2.390 |
Why?
|
| Brain | 77 | 2024 | 27120 | 2.350 |
Why?
|
| Adult Survivors of Child Abuse | 15 | 2023 | 294 | 2.290 |
Why?
|
| Receptor, trkB | 11 | 2017 | 124 | 2.170 |
Why?
|
| Epigenesis, Genetic | 31 | 2023 | 3801 | 2.090 |
Why?
|
| Anxiety | 33 | 2023 | 4573 | 2.040 |
Why?
|
| Stress, Psychological | 27 | 2024 | 4481 | 2.010 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 9 | 2024 | 108 | 1.950 |
Why?
|
| Behavior | 4 | 2023 | 541 | 1.840 |
Why?
|
| Life Change Events | 19 | 2021 | 952 | 1.830 |
Why?
|
| Neuronal Plasticity | 17 | 2024 | 1436 | 1.800 |
Why?
|
| Prefrontal Cortex | 21 | 2024 | 2220 | 1.770 |
Why?
|
| Hippocampus | 27 | 2024 | 3766 | 1.730 |
Why?
|
| Neural Pathways | 17 | 2023 | 3060 | 1.690 |
Why?
|
| Depressive Disorder, Major | 28 | 2024 | 4761 | 1.670 |
Why?
|
| Urban Population | 21 | 2017 | 2036 | 1.650 |
Why?
|
| Resilience, Psychological | 13 | 2024 | 788 | 1.640 |
Why?
|
| Receptors, GABA-A | 7 | 2013 | 623 | 1.630 |
Why?
|
| Anti-Anxiety Agents | 6 | 2014 | 397 | 1.610 |
Why?
|
| Association Learning | 9 | 2015 | 222 | 1.600 |
Why?
|
| Epigenomics | 11 | 2023 | 943 | 1.540 |
Why?
|
| Veterans | 18 | 2023 | 2649 | 1.480 |
Why?
|
| Neurons | 28 | 2024 | 9463 | 1.460 |
Why?
|
| Alprazolam | 4 | 2016 | 102 | 1.450 |
Why?
|
| Behavior, Animal | 22 | 2023 | 1878 | 1.440 |
Why?
|
| Genetic Predisposition to Disease | 49 | 2024 | 17904 | 1.390 |
Why?
|
| DNA Methylation | 28 | 2024 | 4399 | 1.350 |
Why?
|
| Polymorphism, Single Nucleotide | 48 | 2024 | 15936 | 1.350 |
Why?
|
| Animals | 168 | 2024 | 168467 | 1.330 |
Why?
|
| Mental Disorders | 19 | 2021 | 6845 | 1.330 |
Why?
|
| Hypothalamo-Hypophyseal System | 12 | 2022 | 701 | 1.310 |
Why?
|
| Military Personnel | 12 | 2024 | 1246 | 1.300 |
Why?
|
| Cholecystokinin | 5 | 2014 | 117 | 1.300 |
Why?
|
| Phobic Disorders | 6 | 2014 | 439 | 1.290 |
Why?
|
| Depression | 34 | 2023 | 8124 | 1.290 |
Why?
|
| Pituitary-Adrenal System | 12 | 2022 | 552 | 1.290 |
Why?
|
| Receptor, Cannabinoid, CB1 | 4 | 2015 | 137 | 1.260 |
Why?
|
| Wounds and Injuries | 16 | 2021 | 2491 | 1.260 |
Why?
|
| Emotions | 19 | 2023 | 2739 | 1.260 |
Why?
|
| Humans | 385 | 2024 | 761572 | 1.210 |
Why?
|
| Olfactory Pathways | 6 | 2013 | 132 | 1.210 |
Why?
|
| Genome-Wide Association Study | 45 | 2024 | 12690 | 1.200 |
Why?
|
| Male | 256 | 2024 | 360842 | 1.140 |
Why?
|
| Tachykinins | 3 | 2018 | 77 | 1.130 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 7 | 2018 | 89 | 1.120 |
Why?
|
| Smell | 7 | 2014 | 259 | 1.090 |
Why?
|
| Mice, Inbred C57BL | 50 | 2024 | 22172 | 1.070 |
Why?
|
| Gene Expression Regulation | 27 | 2021 | 11904 | 1.070 |
Why?
|
| Receptors, Glucocorticoid | 7 | 2021 | 305 | 1.060 |
Why?
|
| Mice | 96 | 2024 | 81533 | 1.060 |
Why?
|
| Sex Characteristics | 12 | 2024 | 2639 | 1.060 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 4 | 2015 | 324 | 1.050 |
Why?
|
| Autonomic Nervous System | 4 | 2022 | 703 | 1.050 |
Why?
|
| Cues | 14 | 2023 | 875 | 1.050 |
Why?
|
| Social Environment | 6 | 2016 | 1020 | 0.990 |
Why?
|
| Neurosciences | 5 | 2019 | 367 | 0.960 |
Why?
|
| Alcoholism | 7 | 2022 | 1973 | 0.950 |
Why?
|
| Female | 236 | 2024 | 392686 | 0.950 |
Why?
|
| Receptors, Odorant | 13 | 2018 | 67 | 0.940 |
Why?
|
| Adult | 179 | 2024 | 221203 | 0.940 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 7 | 2015 | 895 | 0.930 |
Why?
|
| Maze Learning | 8 | 2013 | 483 | 0.890 |
Why?
|
| Septal Nuclei | 6 | 2015 | 85 | 0.880 |
Why?
|
| Freezing Reaction, Cataleptic | 6 | 2015 | 41 | 0.870 |
Why?
|
| Obsessive-Compulsive Disorder | 5 | 2023 | 1491 | 0.870 |
Why?
|
| Nerve Net | 16 | 2023 | 2291 | 0.860 |
Why?
|
| Psychiatry | 5 | 2020 | 1693 | 0.860 |
Why?
|
| Protein Precursors | 3 | 2018 | 1132 | 0.850 |
Why?
|
| Georgia | 14 | 2017 | 185 | 0.850 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2023 | 129 | 0.830 |
Why?
|
| Inheritance Patterns | 2 | 2015 | 341 | 0.830 |
Why?
|
| beta Catenin | 4 | 2012 | 1040 | 0.820 |
Why?
|
| Olfactory Bulb | 5 | 2019 | 198 | 0.820 |
Why?
|
| Diffusion Tensor Imaging | 15 | 2024 | 2400 | 0.820 |
Why?
|
| Genotype | 27 | 2021 | 12990 | 0.810 |
Why?
|
| Poverty | 8 | 2013 | 2698 | 0.810 |
Why?
|
| Substance-Related Disorders | 9 | 2023 | 4420 | 0.810 |
Why?
|
| Gyrus Cinguli | 8 | 2023 | 1115 | 0.810 |
Why?
|
| Genetic Association Studies | 9 | 2019 | 2735 | 0.800 |
Why?
|
| Receptor, Cholecystokinin B | 2 | 2014 | 6 | 0.800 |
Why?
|
| Lentivirus | 8 | 2014 | 508 | 0.800 |
Why?
|
| Stress Disorders, Traumatic | 2 | 2019 | 50 | 0.790 |
Why?
|
| Stress, Physiological | 4 | 2021 | 1403 | 0.780 |
Why?
|
| Blinking | 3 | 2020 | 133 | 0.780 |
Why?
|
| Hydrocortisone | 12 | 2022 | 1819 | 0.780 |
Why?
|
| Depressive Disorder | 8 | 2017 | 3728 | 0.730 |
Why?
|
| Juvenile Delinquency | 1 | 2021 | 117 | 0.720 |
Why?
|
| Dexamethasone | 15 | 2020 | 1948 | 0.710 |
Why?
|
| Young Adult | 76 | 2024 | 59255 | 0.710 |
Why?
|
| Locomotion | 4 | 2016 | 388 | 0.710 |
Why?
|
| Criminals | 1 | 2021 | 62 | 0.700 |
Why?
|
| Habituation, Psychophysiologic | 4 | 2016 | 147 | 0.700 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2020 | 502 | 0.700 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2021 | 163 | 0.690 |
Why?
|
| Middle Aged | 134 | 2024 | 220920 | 0.690 |
Why?
|
| Mood Disorders | 7 | 2013 | 1127 | 0.680 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2021 | 485 | 0.680 |
Why?
|
| Glutamate Decarboxylase | 3 | 2012 | 239 | 0.680 |
Why?
|
| Violence | 6 | 2023 | 936 | 0.680 |
Why?
|
| Exploratory Behavior | 4 | 2015 | 279 | 0.680 |
Why?
|
| Piperidines | 9 | 2016 | 1656 | 0.660 |
Why?
|
| Magnetic Resonance Imaging | 48 | 2024 | 36429 | 0.660 |
Why?
|
| Heart Rate | 7 | 2024 | 4195 | 0.650 |
Why?
|
| Attention | 7 | 2019 | 2396 | 0.630 |
Why?
|
| Psychiatric Status Rating Scales | 24 | 2021 | 6019 | 0.630 |
Why?
|
| Arousal | 6 | 2019 | 1166 | 0.630 |
Why?
|
| Facial Expression | 10 | 2019 | 508 | 0.620 |
Why?
|
| Acoustic Stimulation | 8 | 2016 | 1235 | 0.620 |
Why?
|
| Angiotensins | 2 | 2018 | 143 | 0.620 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 11 | 2021 | 1988 | 0.620 |
Why?
|
| Child Abuse, Sexual | 3 | 2010 | 403 | 0.620 |
Why?
|
| Synaptic Transmission | 6 | 2014 | 1173 | 0.620 |
Why?
|
| Afghan Campaign 2001- | 2 | 2017 | 298 | 0.610 |
Why?
|
| Signal Transduction | 19 | 2019 | 23447 | 0.610 |
Why?
|
| Mice, Transgenic | 20 | 2021 | 9541 | 0.600 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1787 | 0.600 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2018 | 146 | 0.600 |
Why?
|
| Receptors, Neurokinin-3 | 2 | 2016 | 59 | 0.590 |
Why?
|
| Desensitization, Psychologic | 2 | 2010 | 27 | 0.590 |
Why?
|
| Parenting | 1 | 2024 | 701 | 0.590 |
Why?
|
| Adolescent | 76 | 2024 | 88324 | 0.590 |
Why?
|
| Vagus Nerve | 1 | 2020 | 458 | 0.590 |
Why?
|
| RNA, Messenger | 24 | 2021 | 12794 | 0.580 |
Why?
|
| Avoidance Learning | 5 | 2017 | 248 | 0.580 |
Why?
|
| Disease Models, Animal | 20 | 2023 | 18253 | 0.580 |
Why?
|
| Olfactory Mucosa | 4 | 2015 | 101 | 0.570 |
Why?
|
| Losartan | 3 | 2021 | 265 | 0.560 |
Why?
|
| Brain Mapping | 12 | 2023 | 6635 | 0.560 |
Why?
|
| Transfection | 5 | 2013 | 5774 | 0.560 |
Why?
|
| Geriatric Psychiatry | 1 | 2017 | 71 | 0.550 |
Why?
|
| Combat Disorders | 2 | 2017 | 301 | 0.550 |
Why?
|
| MicroRNAs | 4 | 2019 | 3816 | 0.550 |
Why?
|
| Pleasure | 1 | 2016 | 41 | 0.540 |
Why?
|
| Cerebrum | 2 | 2016 | 132 | 0.530 |
Why?
|
| Happiness | 2 | 2016 | 170 | 0.510 |
Why?
|
| Sodium Channels | 1 | 2017 | 339 | 0.510 |
Why?
|
| Nausea | 1 | 2018 | 679 | 0.510 |
Why?
|
| Renin-Angiotensin System | 3 | 2020 | 737 | 0.500 |
Why?
|
| Carrier Proteins | 8 | 2015 | 4937 | 0.500 |
Why?
|
| Mammals | 4 | 2022 | 1132 | 0.490 |
Why?
|
| Galvanic Skin Response | 4 | 2021 | 358 | 0.470 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 263 | 0.470 |
Why?
|
| Dendritic Spines | 2 | 2018 | 243 | 0.470 |
Why?
|
| Angiotensin Receptor Antagonists | 4 | 2021 | 1039 | 0.470 |
Why?
|
| Sensory Receptor Cells | 3 | 2016 | 513 | 0.470 |
Why?
|
| Toxoplasmosis | 3 | 2021 | 94 | 0.470 |
Why?
|
| Neurobiology | 2 | 2024 | 137 | 0.470 |
Why?
|
| Evoked Potentials | 1 | 2020 | 1047 | 0.470 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 1726 | 0.460 |
Why?
|
| Affect | 4 | 2018 | 1486 | 0.460 |
Why?
|
| C-Reactive Protein | 7 | 2024 | 3826 | 0.460 |
Why?
|
| Proteoglycans | 1 | 2017 | 803 | 0.450 |
Why?
|
| Neurokinin B | 1 | 2014 | 67 | 0.450 |
Why?
|
| Patch-Clamp Techniques | 5 | 2023 | 927 | 0.450 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2021 | 1473 | 0.450 |
Why?
|
| Neuropeptide Y | 2 | 2012 | 192 | 0.440 |
Why?
|
| Nootropic Agents | 1 | 2014 | 157 | 0.440 |
Why?
|
| Ribonuclease III | 1 | 2015 | 279 | 0.440 |
Why?
|
| Child | 52 | 2023 | 80156 | 0.440 |
Why?
|
| Olfactory Receptor Neurons | 4 | 2008 | 96 | 0.440 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2020 | 1516 | 0.440 |
Why?
|
| Geniculate Bodies | 1 | 2014 | 160 | 0.430 |
Why?
|
| CpG Islands | 14 | 2022 | 1230 | 0.430 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2015 | 362 | 0.430 |
Why?
|
| Auditory Cortex | 1 | 2017 | 363 | 0.430 |
Why?
|
| Paternal Exposure | 1 | 2013 | 96 | 0.430 |
Why?
|
| Glutamic Acid | 4 | 2023 | 1176 | 0.430 |
Why?
|
| Receptors, GABA | 1 | 2015 | 313 | 0.430 |
Why?
|
| Rats | 28 | 2021 | 23741 | 0.420 |
Why?
|
| Polyethyleneimine | 1 | 2013 | 68 | 0.420 |
Why?
|
| In Situ Hybridization | 11 | 2012 | 1900 | 0.420 |
Why?
|
| Receptors, Opioid | 1 | 2013 | 145 | 0.420 |
Why?
|
| Estradiol | 3 | 2017 | 1937 | 0.420 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2013 | 74 | 0.420 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 628 | 0.420 |
Why?
|
| Models, Genetic | 6 | 2019 | 3442 | 0.420 |
Why?
|
| Photic Stimulation | 9 | 2016 | 1987 | 0.420 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.420 |
Why?
|
| Genetic Loci | 4 | 2024 | 2632 | 0.410 |
Why?
|
| Panic Disorder | 3 | 2013 | 613 | 0.410 |
Why?
|
| Accidents, Traffic | 7 | 2022 | 816 | 0.410 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2015 | 774 | 0.410 |
Why?
|
| Proteomics | 4 | 2023 | 3848 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 6 | 2014 | 5790 | 0.400 |
Why?
|
| Opioid Peptides | 1 | 2012 | 37 | 0.400 |
Why?
|
| Corpus Striatum | 6 | 2024 | 1235 | 0.400 |
Why?
|
| Insanity Defense | 1 | 2012 | 28 | 0.400 |
Why?
|
| Risk Factors | 47 | 2024 | 74213 | 0.400 |
Why?
|
| Personality Inventory | 7 | 2013 | 1019 | 0.400 |
Why?
|
| Lipoproteins, LDL | 2 | 2022 | 642 | 0.390 |
Why?
|
| Appetite | 1 | 2014 | 247 | 0.390 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2011 | 28 | 0.390 |
Why?
|
| Wnt Proteins | 2 | 2016 | 718 | 0.390 |
Why?
|
| Alleles | 12 | 2023 | 6864 | 0.390 |
Why?
|
| Environment | 3 | 2016 | 1123 | 0.390 |
Why?
|
| Sex Factors | 14 | 2022 | 10553 | 0.380 |
Why?
|
| Neuropsychological Tests | 11 | 2017 | 7054 | 0.380 |
Why?
|
| Patient Care Planning | 1 | 2017 | 909 | 0.380 |
Why?
|
| Wnt1 Protein | 1 | 2011 | 121 | 0.380 |
Why?
|
| Feeding Behavior | 2 | 2023 | 3188 | 0.380 |
Why?
|
| Risperidone | 1 | 2013 | 381 | 0.380 |
Why?
|
| Polymorphism, Genetic | 5 | 2016 | 4243 | 0.370 |
Why?
|
| Analysis of Variance | 11 | 2015 | 6228 | 0.370 |
Why?
|
| Corticosterone | 6 | 2021 | 305 | 0.370 |
Why?
|
| Flavanones | 1 | 2010 | 74 | 0.360 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 431 | 0.360 |
Why?
|
| Lipoproteins, HDL | 2 | 2022 | 676 | 0.360 |
Why?
|
| Genetic Variation | 6 | 2018 | 6567 | 0.360 |
Why?
|
| Neurotensin | 2 | 2022 | 60 | 0.350 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2012 | 1141 | 0.350 |
Why?
|
| Suicide, Attempted | 4 | 2014 | 1402 | 0.350 |
Why?
|
| Longitudinal Studies | 19 | 2024 | 14607 | 0.340 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 7879 | 0.340 |
Why?
|
| Green Fluorescent Proteins | 8 | 2016 | 2065 | 0.340 |
Why?
|
| Phenotype | 20 | 2024 | 16592 | 0.340 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2024 | 727 | 0.340 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2018 | 174 | 0.340 |
Why?
|
| Receptors, Notch | 1 | 2014 | 743 | 0.330 |
Why?
|
| Hypnosis | 1 | 2010 | 82 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 6 | 2015 | 4415 | 0.330 |
Why?
|
| Affective Symptoms | 3 | 2016 | 417 | 0.330 |
Why?
|
| Reward | 4 | 2024 | 971 | 0.330 |
Why?
|
| Suicide | 3 | 2016 | 1601 | 0.330 |
Why?
|
| Expert Testimony | 1 | 2012 | 364 | 0.320 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2013 | 2425 | 0.320 |
Why?
|
| Mental Recall | 4 | 2016 | 1221 | 0.320 |
Why?
|
| Anisotropy | 6 | 2024 | 1283 | 0.320 |
Why?
|
| Cross-Sectional Studies | 23 | 2024 | 26127 | 0.320 |
Why?
|
| Synapses | 4 | 2024 | 1769 | 0.320 |
Why?
|
| Face | 1 | 2015 | 1026 | 0.320 |
Why?
|
| Sensory Gating | 1 | 2009 | 47 | 0.320 |
Why?
|
| Hypothalamus | 7 | 2024 | 999 | 0.320 |
Why?
|
| Psychopathology | 4 | 2023 | 432 | 0.320 |
Why?
|
| Nonlinear Dynamics | 1 | 2011 | 492 | 0.320 |
Why?
|
| Antipsychotic Agents | 3 | 2016 | 3067 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 17 | 2021 | 8181 | 0.320 |
Why?
|
| Community Mental Health Centers | 2 | 2008 | 93 | 0.320 |
Why?
|
| Temporal Lobe | 5 | 2020 | 1695 | 0.310 |
Why?
|
| Acetophenones | 5 | 2018 | 53 | 0.310 |
Why?
|
| Electroconvulsive Therapy | 3 | 2021 | 500 | 0.310 |
Why?
|
| Psychophysiology | 2 | 2021 | 136 | 0.310 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 3 | 2021 | 114 | 0.300 |
Why?
|
| Dependovirus | 1 | 2013 | 718 | 0.300 |
Why?
|
| Comprehension | 1 | 2013 | 621 | 0.300 |
Why?
|
| Molecular Biology | 1 | 2012 | 576 | 0.300 |
Why?
|
| Severity of Illness Index | 17 | 2019 | 15843 | 0.300 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2011 | 370 | 0.300 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 952 | 0.290 |
Why?
|
| Toxoplasma | 2 | 2021 | 157 | 0.290 |
Why?
|
| Models, Neurological | 3 | 2014 | 1769 | 0.290 |
Why?
|
| Motor Vehicles | 7 | 2023 | 282 | 0.290 |
Why?
|
| Estrogens | 5 | 2017 | 1522 | 0.290 |
Why?
|
| Integrases | 4 | 2016 | 518 | 0.290 |
Why?
|
| Endocannabinoids | 1 | 2008 | 111 | 0.290 |
Why?
|
| Triglycerides | 2 | 2022 | 2461 | 0.280 |
Why?
|
| Receptors, Cannabinoid | 1 | 2007 | 43 | 0.280 |
Why?
|
| Wrist | 3 | 2024 | 227 | 0.280 |
Why?
|
| Norepinephrine | 2 | 2000 | 897 | 0.280 |
Why?
|
| Quantitative Trait Loci | 4 | 2016 | 2116 | 0.280 |
Why?
|
| Benzodiazepines | 2 | 2010 | 1132 | 0.280 |
Why?
|
| Electrophysiological Phenomena | 1 | 2009 | 307 | 0.280 |
Why?
|
| Spatial Behavior | 1 | 2007 | 88 | 0.280 |
Why?
|
| Protein Kinase C-delta | 2 | 2018 | 114 | 0.280 |
Why?
|
| Patient Discharge | 2 | 2019 | 3443 | 0.280 |
Why?
|
| Phylogeny | 1 | 2014 | 2811 | 0.270 |
Why?
|
| Mice, Knockout | 12 | 2018 | 14416 | 0.270 |
Why?
|
| Aged | 52 | 2023 | 169310 | 0.270 |
Why?
|
| Motor Activity | 6 | 2018 | 2715 | 0.270 |
Why?
|
| Combined Modality Therapy | 7 | 2019 | 8528 | 0.270 |
Why?
|
| Mice, Mutant Strains | 4 | 2014 | 1749 | 0.260 |
Why?
|
| Minority Groups | 1 | 2013 | 1203 | 0.260 |
Why?
|
| Dyslipidemias | 1 | 2013 | 868 | 0.260 |
Why?
|
| GABA Modulators | 1 | 2006 | 109 | 0.260 |
Why?
|
| Histone Deacetylases | 3 | 2017 | 720 | 0.260 |
Why?
|
| Citalopram | 3 | 2015 | 402 | 0.260 |
Why?
|
| Dopamine | 3 | 2018 | 1607 | 0.260 |
Why?
|
| Habenula | 1 | 2006 | 37 | 0.260 |
Why?
|
| Gene Deletion | 4 | 2021 | 2665 | 0.250 |
Why?
|
| Mesencephalon | 1 | 2007 | 332 | 0.250 |
Why?
|
| Prosencephalon | 1 | 2007 | 305 | 0.250 |
Why?
|
| Genes, Reporter | 3 | 2016 | 1529 | 0.250 |
Why?
|
| Prospective Studies | 19 | 2024 | 54426 | 0.250 |
Why?
|
| Cardiovascular Diseases | 5 | 2023 | 15501 | 0.250 |
Why?
|
| Electromyography | 6 | 2018 | 1394 | 0.250 |
Why?
|
| Down-Regulation | 5 | 2020 | 2919 | 0.250 |
Why?
|
| Length of Stay | 1 | 2019 | 6426 | 0.250 |
Why?
|
| Schizophrenia | 7 | 2023 | 6937 | 0.240 |
Why?
|
| Residence Characteristics | 4 | 2024 | 2094 | 0.240 |
Why?
|
| Glucocorticoids | 7 | 2023 | 2161 | 0.240 |
Why?
|
| Genetic Vectors | 6 | 2013 | 3396 | 0.240 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 3701 | 0.240 |
Why?
|
| Social Behavior | 5 | 2023 | 1135 | 0.240 |
Why?
|
| Demography | 5 | 2021 | 1648 | 0.240 |
Why?
|
| Midazolam | 1 | 2006 | 266 | 0.240 |
Why?
|
| Psychometrics | 6 | 2021 | 3065 | 0.230 |
Why?
|
| Crime | 2 | 2015 | 202 | 0.230 |
Why?
|
| Self Report | 11 | 2023 | 3725 | 0.230 |
Why?
|
| Adaptation, Psychological | 5 | 2017 | 2629 | 0.230 |
Why?
|
| Genetic Markers | 5 | 2016 | 2601 | 0.230 |
Why?
|
| Psychomotor Performance | 1 | 2012 | 1882 | 0.230 |
Why?
|
| Flavones | 3 | 2017 | 68 | 0.230 |
Why?
|
| Pain | 5 | 2023 | 5073 | 0.230 |
Why?
|
| Protein Subunits | 1 | 2007 | 943 | 0.230 |
Why?
|
| Urban Health Services | 1 | 2005 | 177 | 0.230 |
Why?
|
| Survivors | 6 | 2024 | 2371 | 0.220 |
Why?
|
| Melanocortins | 1 | 2023 | 10 | 0.220 |
Why?
|
| Trauma Severity Indices | 3 | 2021 | 478 | 0.220 |
Why?
|
| Cohort Studies | 21 | 2024 | 41493 | 0.220 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 3808 | 0.220 |
Why?
|
| Gene Expression | 10 | 2019 | 7581 | 0.220 |
Why?
|
| Tetrazoles | 1 | 2009 | 909 | 0.220 |
Why?
|
| Telemedicine | 2 | 2019 | 3052 | 0.220 |
Why?
|
| Receptors, AMPA | 2 | 2015 | 336 | 0.220 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 2017 | 144 | 0.210 |
Why?
|
| Aggression | 3 | 2019 | 750 | 0.210 |
Why?
|
| Gene Frequency | 6 | 2021 | 3606 | 0.210 |
Why?
|
| Thalamus | 3 | 2019 | 1047 | 0.210 |
Why?
|
| Hashimoto Disease | 1 | 2024 | 105 | 0.210 |
Why?
|
| Models, Psychological | 4 | 2023 | 829 | 0.210 |
Why?
|
| Receptors, Adrenergic, beta-2 | 4 | 2015 | 215 | 0.210 |
Why?
|
| Inflammation | 8 | 2023 | 10773 | 0.210 |
Why?
|
| Response Elements | 3 | 2015 | 309 | 0.210 |
Why?
|
| Cerebral Cortex | 5 | 2024 | 5779 | 0.210 |
Why?
|
| Long-Term Potentiation | 1 | 2024 | 293 | 0.200 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 2024 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2014 | 9002 | 0.200 |
Why?
|
| Hypnotics and Sedatives | 1 | 2010 | 1179 | 0.200 |
Why?
|
| Electroshock | 4 | 2013 | 121 | 0.200 |
Why?
|
| Internal Capsule | 1 | 2023 | 138 | 0.200 |
Why?
|
| Cognition | 5 | 2021 | 6992 | 0.200 |
Why?
|
| Neural Inhibition | 1 | 2006 | 590 | 0.200 |
Why?
|
| Precipitating Factors | 1 | 2021 | 51 | 0.190 |
Why?
|
| Linkage Disequilibrium | 7 | 2021 | 1998 | 0.190 |
Why?
|
| Punishment | 1 | 2022 | 95 | 0.190 |
Why?
|
| Membrane Proteins | 4 | 2013 | 7858 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2019 | 2518 | 0.190 |
Why?
|
| Repressor Proteins | 4 | 2020 | 2986 | 0.190 |
Why?
|
| Dreams | 1 | 2022 | 146 | 0.190 |
Why?
|
| Models, Animal | 3 | 2020 | 2112 | 0.190 |
Why?
|
| Pyrazoles | 4 | 2015 | 2009 | 0.190 |
Why?
|
| Socioeconomic Factors | 6 | 2012 | 7827 | 0.190 |
Why?
|
| Immobilization | 2 | 2013 | 229 | 0.190 |
Why?
|
| Hospitals, Psychiatric | 2 | 2019 | 321 | 0.180 |
Why?
|
| Ventral Tegmental Area | 2 | 2019 | 136 | 0.180 |
Why?
|
| Statistics as Topic | 3 | 2013 | 2358 | 0.180 |
Why?
|
| Aging | 6 | 2023 | 8711 | 0.180 |
Why?
|
| Criminal Law | 1 | 2021 | 97 | 0.180 |
Why?
|
| Depersonalization | 1 | 2020 | 39 | 0.180 |
Why?
|
| Treatment Outcome | 18 | 2021 | 64684 | 0.180 |
Why?
|
| Double-Blind Method | 6 | 2021 | 12341 | 0.180 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 75 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2010 | 1906 | 0.170 |
Why?
|
| Rape | 2 | 2012 | 131 | 0.170 |
Why?
|
| Bullying | 1 | 2023 | 232 | 0.170 |
Why?
|
| Interneurons | 2 | 2019 | 593 | 0.170 |
Why?
|
| Psychotherapy | 4 | 2023 | 1647 | 0.170 |
Why?
|
| Risk Assessment | 5 | 2024 | 23996 | 0.170 |
Why?
|
| Individuality | 1 | 2021 | 301 | 0.170 |
Why?
|
| Psychotropic Drugs | 2 | 2015 | 888 | 0.170 |
Why?
|
| Habits | 2 | 2017 | 147 | 0.170 |
Why?
|
| Isoenzymes | 1 | 2004 | 1687 | 0.170 |
Why?
|
| Scopolamine | 1 | 2019 | 93 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2020 | 0.170 |
Why?
|
| Alternative Splicing | 1 | 2004 | 1093 | 0.170 |
Why?
|
| Cholinergic Agents | 1 | 2019 | 96 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2014 | 2510 | 0.160 |
Why?
|
| Cannabis | 2 | 2023 | 441 | 0.160 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2021 | 293 | 0.160 |
Why?
|
| Pituitary-Adrenal Function Tests | 4 | 2012 | 30 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8002 | 0.160 |
Why?
|
| Genes, fos | 1 | 2019 | 176 | 0.160 |
Why?
|
| Crime Victims | 1 | 2023 | 347 | 0.160 |
Why?
|
| Endocrine System | 1 | 2019 | 114 | 0.160 |
Why?
|
| Antidepressive Agents | 4 | 2017 | 2897 | 0.160 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2018 | 6 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 10766 | 0.160 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2017 | 86 | 0.160 |
Why?
|
| Ethanol | 2 | 2022 | 1324 | 0.160 |
Why?
|
| Injections, Intraventricular | 2 | 2016 | 225 | 0.150 |
Why?
|
| Microinjections | 2 | 2011 | 321 | 0.150 |
Why?
|
| Calcium Signaling | 1 | 2023 | 733 | 0.150 |
Why?
|
| Cytokines | 2 | 2024 | 7396 | 0.150 |
Why?
|
| Opioid-Related Disorders | 2 | 2024 | 2164 | 0.150 |
Why?
|
| Cell Line | 7 | 2016 | 15601 | 0.150 |
Why?
|
| Nucleus Accumbens | 1 | 2021 | 366 | 0.150 |
Why?
|
| Clozapine | 2 | 2016 | 504 | 0.150 |
Why?
|
| Risk | 7 | 2019 | 9610 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 4352 | 0.150 |
Why?
|
| Social Class | 2 | 2019 | 2004 | 0.150 |
Why?
|
| Ondansetron | 1 | 2018 | 95 | 0.150 |
Why?
|
| Neuregulin-1 | 1 | 2018 | 135 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2013 | 3429 | 0.150 |
Why?
|
| Linguistics | 1 | 2018 | 108 | 0.150 |
Why?
|
| Muscimol | 1 | 2017 | 70 | 0.150 |
Why?
|
| Cells, Cultured | 6 | 2021 | 18965 | 0.150 |
Why?
|
| Designer Drugs | 1 | 2017 | 21 | 0.140 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 150 | 0.140 |
Why?
|
| Regression Analysis | 6 | 2014 | 6344 | 0.140 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 208 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 2 | 2020 | 1342 | 0.140 |
Why?
|
| Telemetry | 1 | 2018 | 199 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2017 | 1250 | 0.140 |
Why?
|
| Comorbidity | 8 | 2023 | 10508 | 0.140 |
Why?
|
| Bipolar Disorder | 4 | 2017 | 5092 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1651 | 0.140 |
Why?
|
| Antiemetics | 1 | 2018 | 186 | 0.140 |
Why?
|
| Receptors, Neurotensin | 1 | 2016 | 16 | 0.140 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 432 | 0.140 |
Why?
|
| Multifactorial Inheritance | 3 | 2021 | 1387 | 0.140 |
Why?
|
| Racemases and Epimerases | 1 | 2017 | 114 | 0.140 |
Why?
|
| N-Methylaspartate | 1 | 2017 | 231 | 0.140 |
Why?
|
| Urban Health | 3 | 2018 | 532 | 0.140 |
Why?
|
| Immunohistochemistry | 6 | 2017 | 11076 | 0.130 |
Why?
|
| Eating | 1 | 2023 | 1539 | 0.130 |
Why?
|
| Cerebellum | 1 | 2024 | 1501 | 0.130 |
Why?
|
| Genomics | 8 | 2021 | 5821 | 0.130 |
Why?
|
| Patient Dropouts | 1 | 2018 | 412 | 0.130 |
Why?
|
| Interview, Psychological | 2 | 2017 | 809 | 0.130 |
Why?
|
| Introns | 2 | 2016 | 981 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2016 | 68 | 0.130 |
Why?
|
| Safety | 1 | 2021 | 1150 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 793 | 0.130 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2016 | 55 | 0.130 |
Why?
|
| Thrombospondins | 1 | 2016 | 193 | 0.130 |
Why?
|
| Autophagy | 1 | 2024 | 1326 | 0.130 |
Why?
|
| Sexual Maturation | 1 | 2017 | 261 | 0.130 |
Why?
|
| Haplotypes | 3 | 2019 | 2713 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2273 | 0.130 |
Why?
|
| Somatostatin | 1 | 2018 | 447 | 0.130 |
Why?
|
| Narration | 1 | 2018 | 219 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2017 | 242 | 0.130 |
Why?
|
| Gene Expression Profiling | 7 | 2024 | 9420 | 0.130 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2017 | 329 | 0.130 |
Why?
|
| Child Behavior | 1 | 2021 | 847 | 0.130 |
Why?
|
| Alcohol Drinking | 3 | 2022 | 4028 | 0.130 |
Why?
|
| Case-Control Studies | 12 | 2022 | 22176 | 0.130 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 69 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 2691 | 0.130 |
Why?
|
| Decision Making | 3 | 2015 | 3929 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 1486 | 0.120 |
Why?
|
| Linear Models | 5 | 2017 | 5872 | 0.120 |
Why?
|
| Cadherins | 2 | 2011 | 903 | 0.120 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 306 | 0.120 |
Why?
|
| Adjustment Disorders | 1 | 2015 | 67 | 0.120 |
Why?
|
| Gene Targeting | 2 | 2010 | 838 | 0.120 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2015 | 65 | 0.120 |
Why?
|
| Memory Disorders | 2 | 2013 | 1199 | 0.120 |
Why?
|
| Histone Deacetylase 2 | 1 | 2015 | 72 | 0.120 |
Why?
|
| United States | 11 | 2024 | 72335 | 0.120 |
Why?
|
| Receptors, Glutamate | 2 | 2006 | 228 | 0.120 |
Why?
|
| Serotonin | 1 | 2000 | 1041 | 0.120 |
Why?
|
| Marijuana Smoking | 1 | 2018 | 258 | 0.120 |
Why?
|
| Culture | 1 | 2019 | 623 | 0.120 |
Why?
|
| Technology | 1 | 2017 | 292 | 0.120 |
Why?
|
| Child of Impaired Parents | 1 | 2018 | 460 | 0.120 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2015 | 153 | 0.120 |
Why?
|
| Leadership | 1 | 2024 | 1385 | 0.120 |
Why?
|
| Valproic Acid | 1 | 2017 | 443 | 0.120 |
Why?
|
| DNA Primers | 2 | 2012 | 2819 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1136 | 0.120 |
Why?
|
| Hyperphagia | 1 | 2015 | 139 | 0.120 |
Why?
|
| Tolloid-Like Metalloproteinases | 1 | 2014 | 7 | 0.120 |
Why?
|
| Proteome | 2 | 2022 | 1862 | 0.120 |
Why?
|
| Histone Deacetylase 1 | 1 | 2015 | 133 | 0.120 |
Why?
|
| Crosses, Genetic | 2 | 2014 | 749 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2015 | 181 | 0.120 |
Why?
|
| 1-Propanol | 1 | 2013 | 15 | 0.120 |
Why?
|
| Hospitals, Public | 2 | 2015 | 202 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2003 | 1509 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2013 | 5035 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2016 | 638 | 0.110 |
Why?
|
| Alcohol-Related Disorders | 1 | 2016 | 238 | 0.110 |
Why?
|
| Stereotaxic Techniques | 1 | 2016 | 555 | 0.110 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2016 | 330 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2019 | 1328 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 837 | 0.110 |
Why?
|
| Spermatozoa | 2 | 2018 | 630 | 0.110 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2009 | 618 | 0.110 |
Why?
|
| Amidohydrolases | 1 | 2014 | 159 | 0.110 |
Why?
|
| Dialysis | 1 | 2013 | 73 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 2020 | 0.110 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2013 | 107 | 0.110 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2015 | 195 | 0.110 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 354 | 0.110 |
Why?
|
| Saliva | 2 | 2016 | 828 | 0.110 |
Why?
|
| Serine | 1 | 2017 | 830 | 0.110 |
Why?
|
| Virus Cultivation | 1 | 2013 | 88 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 2 | 2010 | 413 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3778 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 1120 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2547 | 0.110 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2013 | 299 | 0.110 |
Why?
|
| Autistic Disorder | 1 | 2023 | 1220 | 0.110 |
Why?
|
| Ovariectomy | 1 | 2015 | 614 | 0.110 |
Why?
|
| Methylcellulose | 1 | 2013 | 34 | 0.110 |
Why?
|
| Borderline Personality Disorder | 1 | 2021 | 768 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1886 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2024 | 4016 | 0.110 |
Why?
|
| Pregnancy | 9 | 2022 | 29876 | 0.110 |
Why?
|
| Appetitive Behavior | 1 | 2012 | 39 | 0.110 |
Why?
|
| Parents | 2 | 2024 | 3563 | 0.110 |
Why?
|
| Rodentia | 2 | 2023 | 262 | 0.110 |
Why?
|
| Carbamates | 1 | 2014 | 191 | 0.110 |
Why?
|
| Memory, Long-Term | 1 | 2013 | 59 | 0.100 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 20099 | 0.100 |
Why?
|
| beta-Galactosidase | 1 | 2013 | 574 | 0.100 |
Why?
|
| Manganese Compounds | 1 | 2012 | 25 | 0.100 |
Why?
|
| Territoriality | 1 | 2011 | 6 | 0.100 |
Why?
|
| DNA | 4 | 2014 | 7213 | 0.100 |
Why?
|
| Phosphorus | 1 | 2013 | 336 | 0.100 |
Why?
|
| Hallucinogens | 1 | 2015 | 197 | 0.100 |
Why?
|
| Visual Perception | 1 | 2020 | 1389 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 459 | 0.100 |
Why?
|
| Nitrogen | 1 | 2013 | 348 | 0.100 |
Why?
|
| Diazepam | 1 | 2012 | 215 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4575 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 2244 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2016 | 868 | 0.100 |
Why?
|
| Bronchodilator Agents | 1 | 2015 | 512 | 0.100 |
Why?
|
| Tobacco Use Disorder | 1 | 2017 | 703 | 0.100 |
Why?
|
| Neurosecretory Systems | 2 | 2010 | 223 | 0.100 |
Why?
|
| Electronics | 2 | 2023 | 318 | 0.100 |
Why?
|
| Illinois | 1 | 2011 | 120 | 0.100 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2012 | 115 | 0.090 |
Why?
|
| Repression, Psychology | 1 | 2011 | 46 | 0.090 |
Why?
|
| Desipramine | 1 | 2011 | 182 | 0.090 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2011 | 39 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2019 | 1051 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 878 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2016 | 1187 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 855 | 0.090 |
Why?
|
| Oxygen | 2 | 2013 | 4227 | 0.090 |
Why?
|
| Cluster Analysis | 3 | 2014 | 2707 | 0.090 |
Why?
|
| Brain Concussion | 1 | 2022 | 1404 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3430 | 0.090 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2010 | 20 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3162 | 0.090 |
Why?
|
| Inpatients | 1 | 2022 | 2548 | 0.090 |
Why?
|
| Personality Assessment | 1 | 2013 | 650 | 0.090 |
Why?
|
| Pain Measurement | 3 | 2013 | 3551 | 0.090 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2010 | 74 | 0.090 |
Why?
|
| Limonins | 1 | 2010 | 24 | 0.090 |
Why?
|
| Genes, Immediate-Early | 2 | 2019 | 102 | 0.090 |
Why?
|
| RGS Proteins | 1 | 2010 | 74 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2019 | 2490 | 0.090 |
Why?
|
| Pentylenetetrazole | 1 | 2010 | 71 | 0.090 |
Why?
|
| Eye Movement Desensitization Reprocessing | 1 | 2010 | 5 | 0.090 |
Why?
|
| Social Problems | 1 | 2011 | 109 | 0.090 |
Why?
|
| Glycine | 1 | 2013 | 663 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2010 | 8321 | 0.090 |
Why?
|
| Goals | 1 | 2015 | 711 | 0.090 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2013 | 323 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2015 | 1736 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2019 | 4124 | 0.090 |
Why?
|
| Models, Statistical | 5 | 2019 | 5079 | 0.090 |
Why?
|
| Mothers | 3 | 2022 | 2198 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2024 | 8481 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1899 | 0.090 |
Why?
|
| Conditioning, Operant | 3 | 2017 | 310 | 0.090 |
Why?
|
| Executive Function | 2 | 2016 | 1392 | 0.090 |
Why?
|
| Signal Detection, Psychological | 1 | 2010 | 84 | 0.090 |
Why?
|
| Gerbillinae | 1 | 2009 | 87 | 0.090 |
Why?
|
| Psychophysics | 1 | 2010 | 292 | 0.090 |
Why?
|
| Nasal Mucosa | 1 | 1993 | 416 | 0.090 |
Why?
|
| Menstrual Cycle | 1 | 2013 | 539 | 0.090 |
Why?
|
| Emotional Intelligence | 1 | 2011 | 135 | 0.090 |
Why?
|
| Social Support | 2 | 2011 | 2171 | 0.080 |
Why?
|
| Extremities | 1 | 2015 | 867 | 0.080 |
Why?
|
| RNA | 3 | 2011 | 2726 | 0.080 |
Why?
|
| Neuralgia | 1 | 2016 | 615 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1860 | 0.080 |
Why?
|
| Primary Health Care | 3 | 2011 | 4686 | 0.080 |
Why?
|
| Child Development | 1 | 2021 | 2306 | 0.080 |
Why?
|
| Prevalence | 7 | 2022 | 15732 | 0.080 |
Why?
|
| Pregnant Women | 1 | 2014 | 566 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 1349 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2448 | 0.080 |
Why?
|
| Epithelial Cells | 2 | 2019 | 3677 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3575 | 0.080 |
Why?
|
| Pyridines | 2 | 2012 | 2875 | 0.080 |
Why?
|
| Time Factors | 9 | 2019 | 39970 | 0.080 |
Why?
|
| Titrimetry | 1 | 2009 | 35 | 0.080 |
Why?
|
| Chlorides | 1 | 2012 | 665 | 0.080 |
Why?
|
| Communication | 1 | 2023 | 3873 | 0.080 |
Why?
|
| Child, Preschool | 6 | 2023 | 42230 | 0.080 |
Why?
|
| Limbic System | 1 | 2011 | 419 | 0.080 |
Why?
|
| Personality | 1 | 2013 | 554 | 0.080 |
Why?
|
| Nerve Growth Factors | 2 | 2004 | 564 | 0.080 |
Why?
|
| RNA Interference | 2 | 2020 | 2832 | 0.080 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2010 | 290 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2014 | 8633 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2684 | 0.080 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8601 | 0.080 |
Why?
|
| Aminopyridines | 1 | 2013 | 573 | 0.080 |
Why?
|
| Lasers | 1 | 2013 | 952 | 0.080 |
Why?
|
| Polymers | 1 | 2016 | 1617 | 0.080 |
Why?
|
| Pentagastrin | 1 | 2008 | 17 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 866 | 0.080 |
Why?
|
| Benzamides | 1 | 2014 | 1370 | 0.080 |
Why?
|
| Action Potentials | 1 | 2016 | 1834 | 0.080 |
Why?
|
| Unemployment | 1 | 2010 | 210 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 1134 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6214 | 0.080 |
Why?
|
| Lithium Chloride | 1 | 2008 | 82 | 0.080 |
Why?
|
| Prisoners | 1 | 2012 | 314 | 0.080 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2007 | 30 | 0.080 |
Why?
|
| Birth Weight | 1 | 2016 | 2103 | 0.080 |
Why?
|
| Mental Health | 1 | 2022 | 3250 | 0.070 |
Why?
|
| Smoking | 2 | 2016 | 9053 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2010 | 369 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2019 | 12129 | 0.070 |
Why?
|
| Hypertension | 2 | 2022 | 8540 | 0.070 |
Why?
|
| Friends | 1 | 2009 | 149 | 0.070 |
Why?
|
| Psychological Tests | 3 | 2019 | 640 | 0.070 |
Why?
|
| Domestic Violence | 1 | 2009 | 182 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2014 | 937 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2010 | 1646 | 0.070 |
Why?
|
| Transduction, Genetic | 2 | 2008 | 903 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2022 | 2791 | 0.070 |
Why?
|
| Genome, Human | 3 | 2015 | 4425 | 0.070 |
Why?
|
| International Cooperation | 1 | 2013 | 1422 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 1246 | 0.070 |
Why?
|
| Prognosis | 4 | 2021 | 29629 | 0.070 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2010 | 489 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2013 | 2257 | 0.070 |
Why?
|
| Models, Biological | 2 | 2021 | 9469 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 411 | 0.070 |
Why?
|
| Receptor, PAR-1 | 1 | 2007 | 109 | 0.070 |
Why?
|
| Frontal Lobe | 1 | 2013 | 1420 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 934 | 0.070 |
Why?
|
| Electrolysis | 1 | 2006 | 9 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2468 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2008 | 343 | 0.070 |
Why?
|
| Hospitalization | 3 | 2022 | 10721 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3612 | 0.070 |
Why?
|
| Universities | 1 | 2011 | 993 | 0.070 |
Why?
|
| Apomorphine | 1 | 2006 | 149 | 0.070 |
Why?
|
| Antimetabolites | 1 | 2006 | 129 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2898 | 0.070 |
Why?
|
| Neocortex | 1 | 2010 | 417 | 0.070 |
Why?
|
| Logistic Models | 3 | 2016 | 13255 | 0.060 |
Why?
|
| Pentanols | 1 | 2005 | 4 | 0.060 |
Why?
|
| Software | 2 | 2021 | 4434 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 1886 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2019 | 3271 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4111 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1601 | 0.060 |
Why?
|
| Histones | 1 | 2015 | 2580 | 0.060 |
Why?
|
| Time | 2 | 2018 | 546 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 58986 | 0.060 |
Why?
|
| Neurology | 1 | 2013 | 780 | 0.060 |
Why?
|
| Syndrome | 1 | 2011 | 3267 | 0.060 |
Why?
|
| Infant, Newborn | 5 | 2023 | 26198 | 0.060 |
Why?
|
| Angola | 1 | 2024 | 19 | 0.060 |
Why?
|
| Indole Alkaloids | 1 | 2004 | 23 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2677 | 0.060 |
Why?
|
| Radiography | 1 | 2015 | 6965 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2008 | 635 | 0.060 |
Why?
|
| Age Factors | 3 | 2019 | 18398 | 0.060 |
Why?
|
| Viral Load | 1 | 2013 | 3332 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2014 | 1968 | 0.060 |
Why?
|
| Laboratories | 1 | 2007 | 458 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2264 | 0.060 |
Why?
|
| Plasmids | 1 | 2009 | 2269 | 0.060 |
Why?
|
| Gene Regulatory Networks | 2 | 2024 | 1745 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2024 | 110 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2012 | 1161 | 0.050 |
Why?
|
| Sirolimus | 1 | 2010 | 1533 | 0.050 |
Why?
|
| Transgenes | 1 | 2007 | 1010 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2024 | 4615 | 0.050 |
Why?
|
| Heterozygote | 1 | 2010 | 2787 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 3847 | 0.050 |
Why?
|
| Neurogranin | 1 | 2002 | 15 | 0.050 |
Why?
|
| Suicidal Ideation | 3 | 2019 | 1447 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1699 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39107 | 0.050 |
Why?
|
| Carbazoles | 1 | 2004 | 220 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2012 | 1670 | 0.050 |
Why?
|
| DNA, Circular | 1 | 2022 | 97 | 0.050 |
Why?
|
| Kainic Acid | 1 | 2002 | 203 | 0.050 |
Why?
|
| Entorhinal Cortex | 1 | 2024 | 287 | 0.050 |
Why?
|
| Darkness | 2 | 2012 | 158 | 0.050 |
Why?
|
| Testosterone | 1 | 2013 | 2472 | 0.050 |
Why?
|
| Thalamic Nuclei | 1 | 2022 | 111 | 0.050 |
Why?
|
| Neurites | 1 | 2024 | 391 | 0.050 |
Why?
|
| Computer Simulation | 3 | 2023 | 6241 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2008 | 1400 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2004 | 852 | 0.050 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2002 | 233 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2005 | 785 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2016 | 3223 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2007 | 933 | 0.050 |
Why?
|
| Systems Biology | 1 | 2024 | 481 | 0.040 |
Why?
|
| Afghanistan | 1 | 2020 | 78 | 0.040 |
Why?
|
| Reference Values | 2 | 2019 | 4920 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 10194 | 0.040 |
Why?
|
| Leukocytes | 2 | 2020 | 2026 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 945 | 0.040 |
Why?
|
| Unconsciousness | 1 | 2022 | 250 | 0.040 |
Why?
|
| Neurofilament Proteins | 1 | 2002 | 336 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2012 | 3028 | 0.040 |
Why?
|
| Placebos | 1 | 2004 | 1667 | 0.040 |
Why?
|
| Kynurenine | 1 | 2020 | 141 | 0.040 |
Why?
|
| Circadian Rhythm | 2 | 2022 | 2576 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2006 | 1188 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2005 | 879 | 0.040 |
Why?
|
| Receptors, Adrenergic | 1 | 2000 | 155 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2021 | 374 | 0.040 |
Why?
|
| Policy | 1 | 2023 | 508 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2645 | 0.040 |
Why?
|
| Shame | 1 | 2019 | 80 | 0.040 |
Why?
|
| Reproduction | 2 | 2017 | 645 | 0.040 |
Why?
|
| ROC Curve | 2 | 2021 | 3579 | 0.040 |
Why?
|
| Epithelium | 4 | 2004 | 1603 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2011 | 1852 | 0.040 |
Why?
|
| Cyclohexenes | 1 | 2018 | 15 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 1206 | 0.040 |
Why?
|
| Deep Brain Stimulation | 1 | 2007 | 832 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2024 | 526 | 0.040 |
Why?
|
| Receptors, Serotonin | 1 | 2000 | 208 | 0.040 |
Why?
|
| Contrast Media | 1 | 2012 | 5311 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2020 | 220 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 364 | 0.040 |
Why?
|
| Cordocentesis | 1 | 2018 | 10 | 0.040 |
Why?
|
| Organ Size | 1 | 2024 | 2254 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2022 | 538 | 0.040 |
Why?
|
| Exons | 1 | 2004 | 2391 | 0.040 |
Why?
|
| Algorithms | 3 | 2020 | 14032 | 0.040 |
Why?
|
| Germany | 2 | 2011 | 875 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4513 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7593 | 0.040 |
Why?
|
| Uncertainty | 1 | 2023 | 754 | 0.040 |
Why?
|
| Infant | 4 | 2023 | 36192 | 0.040 |
Why?
|
| Canada | 1 | 2023 | 2122 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 4176 | 0.040 |
Why?
|
| Locus Coeruleus | 1 | 1999 | 230 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2019 | 252 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2024 | 846 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2019 | 712 | 0.040 |
Why?
|
| Aldehydes | 1 | 2018 | 170 | 0.040 |
Why?
|
| Neurophysiology | 1 | 2018 | 144 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2024 | 2329 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 1003 | 0.040 |
Why?
|
| Norway | 1 | 2018 | 499 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2024 | 846 | 0.040 |
Why?
|
| Jews | 1 | 2019 | 356 | 0.030 |
Why?
|
| Multigene Family | 3 | 1996 | 1076 | 0.030 |
Why?
|
| Obesity | 2 | 2022 | 12947 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2016 | 120 | 0.030 |
Why?
|
| Pain Perception | 1 | 2018 | 196 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2017 | 146 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2019 | 749 | 0.030 |
Why?
|
| Asthma | 1 | 2015 | 6234 | 0.030 |
Why?
|
| Sensation | 1 | 2018 | 337 | 0.030 |
Why?
|
| Personality Disorders | 1 | 2021 | 722 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2023 | 1336 | 0.030 |
Why?
|
| Nose | 3 | 1996 | 521 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 12148 | 0.030 |
Why?
|
| Sleep | 2 | 2023 | 4768 | 0.030 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2015 | 40 | 0.030 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2015 | 10 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2013 | 12954 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2015 | 103 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3530 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2021 | 937 | 0.030 |
Why?
|
| Injections | 1 | 2018 | 831 | 0.030 |
Why?
|
| Multilevel Analysis | 1 | 2015 | 150 | 0.030 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2016 | 276 | 0.030 |
Why?
|
| Microglia | 1 | 2024 | 1361 | 0.030 |
Why?
|
| Species Specificity | 1 | 2019 | 2414 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2022 | 1436 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2016 | 302 | 0.030 |
Why?
|
| Rhode Island | 1 | 2015 | 351 | 0.030 |
Why?
|
| Epilepsy | 1 | 2010 | 3290 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2015 | 113 | 0.030 |
Why?
|
| Outpatients | 2 | 2018 | 1597 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2019 | 9319 | 0.030 |
Why?
|
| Germ Cells | 1 | 2018 | 634 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 17635 | 0.030 |
Why?
|
| Genome | 1 | 2022 | 1740 | 0.030 |
Why?
|
| Nepal | 1 | 2015 | 305 | 0.030 |
Why?
|
| Perception | 1 | 2020 | 1197 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2015 | 376 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 2018 | 411 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1742 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2019 | 761 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13510 | 0.030 |
Why?
|
| Metabolomics | 1 | 2023 | 1659 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 1994 | 298 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 12059 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2018 | 765 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 1994 | 13446 | 0.030 |
Why?
|
| Endosomes | 1 | 2016 | 522 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2019 | 2281 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 11670 | 0.030 |
Why?
|
| Endocytosis | 2 | 2010 | 957 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3713 | 0.030 |
Why?
|
| Calcium Channels | 1 | 2017 | 620 | 0.030 |
Why?
|
| Cholesterol | 1 | 2022 | 2904 | 0.030 |
Why?
|
| Human Characteristics | 1 | 2013 | 7 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2016 | 656 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2017 | 518 | 0.030 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2012 | 39 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 500 | 0.030 |
Why?
|
| Catheterization | 2 | 2013 | 1428 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 1756 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2880 | 0.030 |
Why?
|
| Receptors, Thrombin | 1 | 2013 | 130 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2016 | 617 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 815 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 851 | 0.030 |
Why?
|
| South Africa | 1 | 2018 | 1843 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1616 | 0.030 |
Why?
|
| Longevity | 1 | 2020 | 1065 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 1702 | 0.030 |
Why?
|
| Genes, RAG-1 | 1 | 2012 | 67 | 0.030 |
Why?
|
| Arrhythmia, Sinus | 1 | 2012 | 48 | 0.030 |
Why?
|
| Mentally Ill Persons | 1 | 2013 | 128 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1994 | 2748 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1530 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2010 | 3792 | 0.020 |
Why?
|
| Raphe Nuclei | 1 | 2012 | 103 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2011 | 252 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2013 | 279 | 0.020 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2011 | 18 | 0.020 |
Why?
|
| Psychotherapy, Brief | 1 | 2012 | 118 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2018 | 1347 | 0.020 |
Why?
|
| Cities | 1 | 2014 | 546 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 779 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2013 | 186 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2012 | 345 | 0.020 |
Why?
|
| Research Design | 2 | 2019 | 6180 | 0.020 |
Why?
|
| Tritium | 1 | 2011 | 708 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 103 | 0.020 |
Why?
|
| Curriculum | 1 | 2024 | 3743 | 0.020 |
Why?
|
| Respiratory Rate | 1 | 2012 | 176 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2015 | 583 | 0.020 |
Why?
|
| Forecasting | 1 | 2019 | 2928 | 0.020 |
Why?
|
| Health Personnel | 1 | 2024 | 3335 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 5440 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1989 | 63 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 1989 | 75 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 3889 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2008 | 5336 | 0.020 |
Why?
|
| Receptors, Vasopressin | 1 | 2010 | 106 | 0.020 |
Why?
|
| Valine | 1 | 2011 | 408 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2015 | 944 | 0.020 |
Why?
|
| Prejudice | 1 | 2014 | 570 | 0.020 |
Why?
|
| Food Deprivation | 1 | 1989 | 114 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 430 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 819 | 0.020 |
Why?
|
| Calcium | 1 | 2022 | 5722 | 0.020 |
Why?
|
| Methionine | 1 | 2011 | 572 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2012 | 849 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 305 | 0.020 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2008 | 47 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 576 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 1881 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 2008 | 125 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2017 | 1081 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 4542 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4740 | 0.020 |
Why?
|
| Students | 1 | 2018 | 1741 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 320 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 2423 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2022 | 6391 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1505 | 0.020 |
Why?
|
| Motivation | 1 | 2017 | 2006 | 0.020 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 3358 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2017 | 2180 | 0.020 |
Why?
|
| Biophysics | 1 | 2009 | 380 | 0.020 |
Why?
|
| Sexual Behavior, Animal | 1 | 2008 | 120 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3208 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2007 | 40 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 1848 | 0.020 |
Why?
|
| Swimming | 1 | 2008 | 208 | 0.020 |
Why?
|
| Causality | 1 | 2013 | 1242 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2007 | 69 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 909 | 0.020 |
Why?
|
| Lac Operon | 1 | 2007 | 237 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2011 | 495 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 80646 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4544 | 0.020 |
Why?
|
| Axons | 1 | 1994 | 1674 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9326 | 0.020 |
Why?
|
| Health Surveys | 1 | 2016 | 4061 | 0.020 |
Why?
|
| Transportation | 1 | 2008 | 217 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2007 | 3687 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 2057 | 0.020 |
Why?
|
| Genes | 1 | 2010 | 1823 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2011 | 1380 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 150 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5247 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1090 | 0.020 |
Why?
|
| Analgesics | 1 | 2012 | 1070 | 0.020 |
Why?
|
| Flunitrazepam | 1 | 2005 | 20 | 0.020 |
Why?
|
| Protein Binding | 2 | 2010 | 9353 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 983 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 934 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3359 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2016 | 2057 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3517 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3597 | 0.010 |
Why?
|
| Lysine | 1 | 2009 | 993 | 0.010 |
Why?
|
| Motor Skills | 1 | 2007 | 521 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15266 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5112 | 0.010 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2004 | 111 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 6075 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3639 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8656 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4280 | 0.010 |
Why?
|
| Family Health | 1 | 2008 | 1257 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1809 | 0.010 |
Why?
|
| Photosensitizing Agents | 1 | 2007 | 623 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2018 | 6237 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5439 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4811 | 0.010 |
Why?
|
| Base Sequence | 1 | 1993 | 12441 | 0.010 |
Why?
|
| Body Weight | 1 | 2012 | 4618 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2002 | 397 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 2002 | 116 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2002 | 614 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2012 | 5485 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3769 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3511 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4948 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 1967 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1971 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2011 | 6377 | 0.010 |
Why?
|
| Liver | 1 | 1993 | 7529 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14666 | 0.010 |
Why?
|
| Cations | 1 | 1995 | 238 | 0.010 |
Why?
|
| Health Status | 1 | 2008 | 4077 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 1058 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 915 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 9489 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16986 | 0.010 |
Why?
|
| Vertebrates | 1 | 1994 | 227 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2004 | 1730 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7047 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 951 | 0.010 |
Why?
|
| Ion Channels | 1 | 1995 | 1040 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1996 | 2341 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4174 | 0.010 |
Why?
|
| Cilia | 1 | 1994 | 495 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1994 | 2180 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1989 | 563 | 0.000 |
Why?
|
| Mass Screening | 1 | 2004 | 5428 | 0.000 |
Why?
|
| Amino Acids | 1 | 1989 | 1718 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11530 | 0.000 |
Why?
|
| Diet | 1 | 1989 | 8075 | 0.000 |
Why?
|
| Mutation | 1 | 1995 | 30054 | 0.000 |
Why?
|